Ex Vivo Major Histocompatibility Complex I Knockdown Prolongs Rejection-free Allograft Survival

Background:. Widespread application of vascularized composite allotransplantation (VCA) is currently limited by the required lifelong systemic immunosuppression and its associated morbidity and mortality. This study evaluated the efficacy of ex vivo (after procurement but before transplantation) eng...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Jessica B. Chang, MD, William J. Rifkin, BA, Marc A. Soares, MD, April Duckworth, MD, Nakul Rao, MD, Yee Cheng Low, MD, Jonathan P. Massie, MD, Piul S. Rabbani, PhD, Pierre B. Saadeh, MD, Daniel J. Ceradini, MD
Format:	Artigo
Sprog:	Inglês
Udgivet:	Wolters Kluwer 2018-06-01
Serier:	Plastic and Reconstructive Surgery, Global Open
Online adgang:	http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000001825
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!